The Cathode-Electrolyte Interface Constructed with Antioxidant Ascorbic Acid Guides LNMO to Achieve Stable Cycling Under High Voltage Conditions.

LiNiMnO (LNMO) is considered one of the most promising cathode materials for high-energy-density lithium-ion batteries (LIBs). However, free-radical-induced carbonate electrolyte decomposition is a key factor hindering the improvement of battery stability. Inspired by the antioxidative properties of ascorbic acid (AA) in scavenging free radicals, the addition of AA during the electrode fabrication process can effectively terminate free radical chain reactions within the cycling of LNMO.

Alginate-Xylan Biopolymer as a Multifunctional Binder for 5 V High-Voltage LNMO Electrodes.

LiNiMnO (LNMO) with a spinel structure is one of the most promising cathode materials choices for Li-ion batteries (LIBs). However, at a high operating voltages, the decomposition of organic electrolytes and the dissolution of transition metals, especially Mn(II) ions, cause unsatisfactory cycle stability. The initial application of a sodium alginate (SA)-xylan biopolymer as an aqueous binder aims to address the aforementioned problems.

In Situ Preparation of High-Performance Silicon-Based Integrated Electrodes Using Cross-Linked Cyclodextrins.

The strategy of material modification for improving the stability of silicon electrodes is laborious and costly, while the conventional binders cannot withstand the repeated massive volume variability of silicon-based materials. Hence, there is a demand to settle the silicon-based materials' problems with green and straightforward solutions. This paper presents a high-performance silicon anode with a binder obtained by in situ thermal cross-linking of citric acid (CA) and β-cyclodextrin (β-CD) during the electrode preparation process.

Enhancing Hydrogen Oxidation and Evolution Kinetics by Tuning the Interfacial Hydrogen-Bonding Environment on Functionalized Platinum Surfaces.

Developing efficient catalytic systems for the hydrogen oxidation and evolution reactions (HOR/HER) is essential in the world's transition to renewable energy. There is a growing recognition that the HOR/HER activity depends on properties of the electrochemical interface, rather than just the composition and structure of the catalyst. Herein, we demonstrate that specifically adsorbed organic additives (theophylline derivatives) could enhance the intrinsic HOR/HER activity in base on polycrystalline Pt by up to a factor of 3 via introducing weakly hydrogen-bonded water, as confirmed by in situ surface enhanced infrared and Raman spectroscopies.

Cross-linked β-CD-CMC as an effective aqueous binder for silicon-based anodes in rechargeable lithium-ion batteries.

As a non-active material component, the binder can effectively maintain the integrity of battery electrodes. In this work, based on the inspired structure of fishing nets, a three-dimensional mesh adhesive using widely sourced raw materials CMC and β-CD was designed. These cross-linked cyclodextrins have the advantage of dispersing the stress at the anchor point and moderating the significant volume changes of the Si anode.

Design, synthesis and biological evaluation of hydantoin derivatives as Mcl-1 selective inhibitors.

As a member of Bcl-2 protein family, myeloid cell leukemia-1 (Mcl-1) plays a critical role in cell apoptosis and has become a promising anti-cancer drug target. Herein, we designed and synthesized a series of hydantoin derivatives as novel Mcl-1 inhibitors based on our previously developed lead compound. Among them, compound M23 and M24 exhibited good binding affinities against Mcl-1 with K values of 0.

Design, synthesis and preliminary bioactivity studies of indomethacin derivatives as Bcl-2/Mcl-1 dual inhibitors.

Bcl-2 family proteins, which divides into pro-apoptosis proteins and anti-apoptosis proteins, are involved in cell apoptosis progression. As numerous studies illustrated, targeting Bcl-2 family proteins is more and more attractive and practicable to cancer treatment. In this work, we designed and synthesized a series of indomethacin derivatives as new inhibitors for Bcl-2 family proteins.